ADAMTS13 Plays a Novel Role in Hyperfibrinolysis After Trauma-Induced Shock
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, reposted from Derek Kleinveld on LinkedIn:
”Thank you Derek Kleinveld for the opportunity to collaborate with my group.”
Quoting Derek Kleinveld‘s post:
”Happy to share our latest publication on a novel role for ADAMTS13 in trauma-induced shock. Thanks to all collaborators!”
Title: A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock
Authors: Pieter H. Sloos, Lisa Vermeersch, Daphne S. Roozendaal, Anne-Sophie Delmote, Cornelis van ‘t Veer, Thomas O. Momanyi, Frida Z. Miranda, Joshua Muia, Claudia Tersteeg, Karen Vanhoorelbeke, Nicole P. Juffermans, Derek J.B. Kleinveld
Read the full article here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering